{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:33:00Z","timestamp":1781821980877,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,5]]},"DOI":"10.7759\/cureus.76959","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T21:03:58Z","timestamp":1736111038000},"source":"Crossref","is-referenced-by-count":1,"title":["Diastolic Dysfunction and Renal Disease: Analysis, Mechanisms, and Different Perspectives"],"prefix":"10.7759","author":[{"given":"Joana","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.793471","article-title":"Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population","volume":"119","author":"Mogelvang R","year":"2009","unstructured":"Mogelvang R, Sogaard P, Pedersen SA, et al.. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation. 2009, 119:2679-85. 10.1161\/CIRCULATIONAHA.108.793471","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.057","article-title":"Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning: is it a reliable marker in detecting coronary artery disease?","volume":"53","author":"Ishii K","year":"2009","unstructured":"Ishii K, Imai M, Suyama T, Maenaka M, Nagai T, Kawanami M, Seino Y. Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning: is it a reliable marker in detecting coronary artery disease?. J Am Coll Cardiol. 2009, 53:698-705. 10.1016\/j.jacc.2008.09.057","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann F","year":"2013","unstructured":"Edelmann F, Wachter R, Schmidt AG, et al.. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013, 309:781-91. 10.1001\/jama.2013.905","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00391-012-0345-z","article-title":"Diastolic heart failure: heart failure with preserved ejection fraction (Article in German)","volume":"46","author":"Dovjak P","year":"2013","unstructured":"Dovjak P. Diastolic heart failure: heart failure with preserved ejection fraction (Article in German). Z Gerontol Geriatr. 2013, 46:71-9. 10.1007\/s00391-012-0345-z","journal-title":"Z Gerontol Geriatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak MJ","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, et al.. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003, 108:2154-69. 10.1161\/01.CIR.0000095676.90936.80","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/8756479319836781","article-title":"Diastolic dysfunction and the new recommendations for echocardiographic assessment of left ventricular diastolic function: summary of guidelines and novelties in diagnosis and grading","volume":"35","author":"Kossaify A","year":"2019","unstructured":"Kossaify A, Nasr M. Diastolic dysfunction and the new recommendations for echocardiographic assessment of left ventricular diastolic function: summary of guidelines and novelties in diagnosis and grading. J Diagn Med Sonogr. 2019, 35:317-25. 10.1177\/8756479319836781","journal-title":"J Diagn Med Sonogr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.062950","article-title":"Current perspectives in diastolic dysfunction and diastolic heart failure","volume":"92","author":"Leite-Moreira AF","year":"2006","unstructured":"Leite-Moreira AF. Current perspectives in diastolic dysfunction and diastolic heart failure. Heart. 2006, 92:712-8. 10.1136\/hrt.2005.062950","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile MR","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004, 350:1953-9. 10.1056\/NEJMoa032566","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005030270","article-title":"Kidney function and mortality among patients with left ventricular systolic dysfunction","volume":"17","author":"Khan NA","year":"2006","unstructured":"Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, Levin A. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol. 2006, 17:244-53. 10.1681\/ASN.2005030270","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10123-8","article-title":"Right ventricular diastolic dysfunction and failure: a review","volume":"27","author":"Jung YH","year":"2022","unstructured":"Jung YH, Ren X, Suffredini G, Dodd-O JM, Gao WD. Right ventricular diastolic dysfunction and failure: a review. Heart Fail Rev. 2022, 27:1077-90. 10.1007\/s10741-021-10123-8","journal-title":"Heart Fail Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12105","article-title":"Duration of migraine is associated with cardiac diastolic dysfunction","volume":"14","author":"Ekici B","year":"2013","unstructured":"Ekici B, Unal-Cevik I, Akgul-Ercan E, Morkavuk G, Yakut Y, Erkan AF. Duration of migraine is associated with cardiac diastolic dysfunction. Pain Med. 2013, 14:988-93. 10.1111\/pme.12105","journal-title":"Pain Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske B","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al.. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019, 40:3297-317. 10.1093\/eurheartj\/ehz641","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319605","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert AB","year":"2022","unstructured":"Gevaert AB, Kataria R, Zannad F, et al.. Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management. Heart. 2022, 108:1342-50. 10.1136\/heartjnl-2021-319605","journal-title":"Heart"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000481","article-title":"Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction","volume":"6","author":"Hummel SL","year":"2013","unstructured":"Hummel SL, Seymour EM, Brook RD, et al.. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ Heart Fail. 2013, 6:1165-71. 10.1161\/CIRCHEARTFAILURE.113.000481","journal-title":"Circ Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1776","article-title":"Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure","volume":"22","author":"Dewan P","year":"2020","unstructured":"Dewan P, Jackson A, Lam CS, et al.. Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure. Eur J Heart Fail. 2020, 22:898-901. 10.1002\/ejhf.1776","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.04.009","article-title":"Integrating high-sensitivity troponin T and sacubitril\/valsartan treatment in HFpEF: the PARAGON-HF trial","volume":"9","author":"Gori M","year":"2021","unstructured":"Gori M, Senni M, Claggett B, et al.. Integrating high-sensitivity troponin T and sacubitril\/valsartan treatment in HFpEF: the PARAGON-HF trial. JACC Heart Fail. 2021, 9:627-35. 10.1016\/j.jchf.2021.04.009","journal-title":"JACC Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker SD","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, et al.. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021, 385:1451-61. 10.1056\/NEJMoa2107038","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000074934","article-title":"Chronic kidney disease and sudden death: strategies for prevention","volume":"22","author":"McCullough PA","year":"2004","unstructured":"McCullough PA, Sandberg KR. Chronic kidney disease and sudden death: strategies for prevention. Blood Purif. 2004, 22:136-42. 10.1159\/000074934","journal-title":"Blood Purif"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi020","article-title":"The severe cardiorenal syndrome: 'Guyton revisited'","volume":"26","author":"Bongartz LG","year":"2005","unstructured":"Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J. 2005, 26:11-7. 10.1093\/eurheartj\/ehi020","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.10.007","article-title":"US Renal Data System 2010 annual data report","volume":"57","author":"Collins AJ","year":"2011","unstructured":"Collins AJ, Foley RN, Herzog C, et al.. US Renal Data System 2010 annual data report. Am J Kidney Dis. 2011, 57:A8. 10.1053\/j.ajkd.2010.10.007","journal-title":"Am J Kidney Dis"},{"key":"ref22","article-title":"S\u00edndrome cardio-renal os desafios no tratamento da insufici\u00eancia card\u00edaca (Article in Portugese)","volume":"24","author":"Martins H","year":"2011","unstructured":"Martins H, Pedro N, Castellano M, Monteiro P, Moura JJ, Procidencia LA. S\u00edndrome cardio-renal os desafios no tratamento da insufici\u00eancia card\u00edaca (Article in Portugese). Acta Med Port. 2011, 24:285-92.","journal-title":"Acta Med Port"},{"key":"ref23","article-title":"Chronic Kidney Disease","author":"Vaidya SR","year":"2024","unstructured":"Vaidya SR, Aeddula NR. Chronic Kidney Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref24","article-title":"Left ventricular dysfunction in the early stage of chronic kidney disease","volume":"61","author":"Otsuka T","year":"2013","unstructured":"Otsuka T, Susuki M, Yoshikawa M, Sugi K. Left ventricular dysfunction in the early stage of chronic kidney disease. J Cardiol. 2013, 61:169-74.","journal-title":"J Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jjcc.2012.08.020","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population","volume":"61","author":"Matsue Y","year":"2013","unstructured":"Matsue Y, Susuki M, Seya M, et al.. Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. J Cardiol. 2013, 61:74.","journal-title":"J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2012.08.020","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population","volume":"61","author":"Matsue Y","year":"2013","unstructured":"Matsue Y, Suzuki M, Seya M, et al.. Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. J Cardiol. 2013, 61:169-74. 10.1016\/j.jjcc.2012.08.020","journal-title":"J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-280","article-title":"Diastolic function is a strong predictor of mortality in patients with chronic kidney disease","volume":"14","author":"Farshid A","year":"2013","unstructured":"Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol. 2013, 14:280. 10.1186\/1471-2369-14-280","journal-title":"BMC Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier RW","year":"2006","unstructured":"Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?. J Am Coll Cardiol. 2006, 47:1-8. 10.1016\/j.jacc.2005.07.067","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1258\/ebm.2011.011175","article-title":"Endogenous aldosterone is involved in vascular calcification in rat","volume":"237","author":"Wu SY","year":"2012","unstructured":"Wu SY, Yu YR, Cai Y, et al.. Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood). 2012, 237:31-7. 10.1258\/ebm.2011.011175","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2012.06.031","article-title":"Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease","volume":"126","author":"Ahmed A","year":"2013","unstructured":"Ahmed A, Rich MW, Zile M, et al.. Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med. 2013, 126:150-61.","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00859.2013","article-title":"Role of estrogen in diastolic dysfunction","volume":"306","author":"Zhao Z","year":"2014","unstructured":"Zhao Z, Wang H, Jessup JA, Lindsey SH, Chappell MC, Groban L. Role of estrogen in diastolic dysfunction. Am J Physiol Heart Circ Physiol. 2014, 306:H628-40. 10.1152\/ajpheart.00859.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00194.2011","article-title":"Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection","volume":"302","author":"Martin FL","year":"2012","unstructured":"Martin FL, McKie PM, Cataliotti A, et al.. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol. 2012, 302:R292-9. 10.1152\/ajpregu.00194.2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp747","article-title":"Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis","volume":"25","author":"Losi MA","year":"2010","unstructured":"Losi MA, Memoli B, Contaldi C, et al.. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant. 2010, 25:1950-4. 10.1093\/ndt\/gfp747","journal-title":"Nephrol Dial Transplant"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-013-0739-z","article-title":"Impaired renal function is a major determinant of left ventricular diastolic dysfunction: assessment by stress myocardial perfusion imaging","volume":"27","author":"Sato W","year":"2013","unstructured":"Sato W, Kosaka T, Koyama T, Ishida M, Iino K, Watanabe H, Ito H. Impaired renal function is a major determinant of left ventricular diastolic dysfunction: assessment by stress myocardial perfusion imaging. Ann Nucl Med. 2013, 27:729-36. 10.1007\/s12149-013-0739-z","journal-title":"Ann Nucl Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5603\/KP.2013.0061","article-title":"Evaluation of left atrial function using two-dimensional speckle tracking echocardiography in end-stage renal disease patients with preserved left ventricular ejection fraction","volume":"71","author":"Altekin RE","year":"2013","unstructured":"Altekin RE, Yanikoglu A, Karakas MS, Ozel D, Yilmaz H, Demir I. Evaluation of left atrial function using two-dimensional speckle tracking echocardiography in end-stage renal disease patients with preserved left ventricular ejection fraction. Kardiol Pol. 2013, 71:341-51. 10.5603\/KP.2013.0061","journal-title":"Kardiol Pol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn596","article-title":"Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study","volume":"30","author":"Mogelvang R","year":"2009","unstructured":"Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Schnohr P, Jensen JS. Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study. Eur Heart J. 2009, 30:731-9. 10.1093\/eurheartj\/ehn596","journal-title":"Eur Heart J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jer105","article-title":"Hypocalcaemia-induced transient dilated cardiomyopathy in elderly: a case report","volume":"12","author":"Behaghel A","year":"2011","unstructured":"Behaghel A, Donal E. Hypocalcaemia-induced transient dilated cardiomyopathy in elderly: a case report. Eur J Echocardiogr. 2011, 12:E38. 10.1093\/ejechocard\/jer105","journal-title":"Eur J Echocardiogr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2013.08.003","article-title":"Hypocalcemia is related to left ventricular diastolic dysfunction in patients with chronic kidney disease","volume":"63","author":"Gromadzi\u0144ski L","year":"2014","unstructured":"Gromadzi\u0144ski L, Januszko-Giergielewicz B, Pruszczyk P. Hypocalcemia is related to left ventricular diastolic dysfunction in patients with chronic kidney disease. J Cardiol. 2014, 63:198-204. 10.1016\/j.jjcc.2013.08.003","journal-title":"J Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-5-201003020-00010","article-title":"Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events","volume":"152","author":"Wang L","year":"2010","unstructured":"Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010, 152:315-23. 10.7326\/0003-4819-152-5-201003020-00010","journal-title":"Ann Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28097","article-title":"Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial","volume":"91","author":"Reid IR","year":"2010","unstructured":"Reid IR, Ames R, Mason B, et al.. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr. 2010, 91:131-9. 10.3945\/ajcn.2009.28097","journal-title":"Am J Clin Nutr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.3283","article-title":"Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study","volume":"173","author":"Xiao Q","year":"2013","unstructured":"Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013, 173:639-46. 10.1001\/jamainternmed.2013.3283","journal-title":"JAMA Intern Med"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1093\/eurjhf\/hfr016","article-title":"Parathyroid hormone and vitamin D - markers for cardiovascular and all cause mortality in heart failure","volume":"13","author":"Schierbeck LL","year":"2011","unstructured":"Schierbeck LL, Jensen TS, Bang U, et al.. Parathyroid hormone and vitamin D - markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail. 2011, 13:626-632.","journal-title":"Eur J Heart Fail"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0805","article-title":"Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility","volume":"149","author":"Tishkoff DX","year":"2008","unstructured":"Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology. 2008, 149:558-64. 10.1210\/en.2007-0805","journal-title":"Endocrinology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.04.153","article-title":"Low vitamin D levels are related to left ventricular concentric remodelling in men of different ethnic groups with varying cardiovascular risk","volume":"158","author":"Rezai MR","year":"2012","unstructured":"Rezai MR, Balakrishnan Nair S, Cowan B, et al.. Low vitamin D levels are related to left ventricular concentric remodelling in men of different ethnic groups with varying cardiovascular risk. Int J Cardiol. 2012, 158:444-7. 10.1016\/j.ijcard.2012.04.153","journal-title":"Int J Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0000000000000008","article-title":"Serum vitamin D and C-reactive protein levels are independently associated with diastolic dysfunction","volume":"62","author":"Akin F","year":"2014","unstructured":"Akin F, Ay\u00e7a B, K\u00f6se N, et al.. Serum vitamin D and C-reactive protein levels are independently associated with diastolic dysfunction. J Investig Med. 2014, 62:43-8. 10.2310\/JIM.0000000000000008","journal-title":"J Investig Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez OM","year":"2009","unstructured":"Guti\u00e9rrez OM, Januzzi JL, Isakova T, et al.. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009, 119:2545-52. 10.1161\/CIRCULATIONAHA.108.844506","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.01.019","article-title":"The effect of vitamin d on aldosterone and health status in patients with heart failure","volume":"20","author":"Boxer RS","year":"2014","unstructured":"Boxer RS, Hoit BD, Schmotzer BJ, Stefano GT, Gomes A, Negrea L. The effect of vitamin d on aldosterone and health status in patients with heart failure. J Card Fail. 2014, 20:334-42. 10.1016\/j.cardfail.2014.01.019","journal-title":"J Card Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/228482-diastolic-dysfunction-and-renal-disease-analysis-mechanisms-and-different-perspectives","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T21:04:01Z","timestamp":1736111041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/228482-diastolic-dysfunction-and-renal-disease-analysis-mechanisms-and-different-perspectives"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,5]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.76959","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,5]]}}}